NCT02463266 Evaluation of the PACE/PACENET BHL Clinical Program
| NCT ID | NCT02463266 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2014-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2014-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among beneficiaries in the SUSTAIN Clinical Program and b) to evaluate the sustained clinical effects of the program.
Eligibility Criteria
Inclusion Criteria: 1. Aged 65 and older, males and females. 2. Participating in the SUSTAIN Clinical Program 3. For the 6 Month Outcome Research Evaluation, in addition to meeting criteria 1 and 2, willing to provide verbal informed consent to participate in the 6 Month Outcome Research Evaluation at the end of the acute phase of clinical care, usually at three months. Exclusion Criteria: * Not meeting the inclusion criteria listed above.
Contact & Investigator
Mary Beth Gibbons, PhD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT02463266 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02463266 currently recruiting?
Yes, NCT02463266 is actively recruiting participants. Contact the research team at gibbonsm@pennmedicine.upenn.edu for enrollment information.
Where is the NCT02463266 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT02463266 clinical trial?
NCT02463266 is sponsored by University of Pennsylvania. The principal investigator is Mary Beth Gibbons, PhD at University of Pennsylvania. The trial plans to enroll 4,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.